Publications

5600 Results

Review of SWOG S1314: Lessons from a randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer [Review]

Authors
P Boxley;M Plets;T Flaig
Journal / Conference
Bladder Cancer Jun 11;6(2):123-129
Year
2020
Research Committee(s)
Genitourinary
PMID
PMID32793789
PMC
PMC7390592
Study Number(s)
S1314

A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC): COlorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study (NRG-GI004/SWOG-S1610)

Authors
CMS Rocha Lima;G Yothers;SA Jacobs;H Sanoff;DJ Cohen;K Guthrie;NL Henry;P Ganz;ES Kopetz;PC Lucas;CJ Allegra;CD Blanke;N Wolmark;HS Hochster;TJ George;MJ Overman
Journal / Conference
J Clin Oncol 38, 2020 (suppl 4; abstr TPS260); ASCO GI Cancers Symposium (January 23-25, 2020, San Francisco, CA)
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/NRG-GI004

Immune related adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants and association with outcome: E1609 study analysis

Authors
A Tarhini;S Lee;N Kang;F Hodi;U Rao;G Cohen;L Flaherty;T Patrella;V Sondak;JM Kirkwood
Journal / Conference
ASCO-SITC Clinical Immuno-Oncology Symposium (Feb 6-8, 2020, Orlando, FL), Poster Session (Board #C7)
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

INTACT: Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer: SWOG/NRG S1806

Authors
P Singh;C Tangen;J Efstathiou;S Jhavar;N Hahn;B Costello;S Sridhar;W Du;J Meeks;B Faltas;P Grivas;F Feng;RC Cheng;A Morgans;A Gupta;R Bangs;K Winter;N Vogelzang;S Lerner;IM Thompson
Journal / Conference
J Clin Oncol 38, 2020 (suppl 6; abstr TPS586); ASCO GU Cancers Symposium (Feb 13-15, 2020, San Francisco, CA), trials in progress
Year
2020
Research Committee(s)
Genitourinary
Study Number(s)
S1806

Changes in blood levels of prostate kallikrein-related and microseminoprotein-beta marker levels follogin 5ARI therapy: data from 500 PCPT-participants

Authors
E Vertosick;A Vickers;P Goodman;H Lilja
Journal / Conference
Journal of Urology Vol 203 Issue Suppl 4 April Page: e1092-e1093; (AUA Annual Meeting May 15-18, 2020, Washington DC) #PD52-08, poster
Year
2020
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Bias in mean survival from fitting cure models with limited follow-up

Authors
M Othus;A Bansal;H Erba;S Ramsey
Journal / Conference
Value in Health Aug;23(8):1034-1039
Year
2020
Research Committee(s)
Leukemia
PMID
PMID32828215
PMC
PMC7446760
Study Number(s)
S0106, S0325, S0703, S0805, S1117, S1203

What Keeps Patients Out of Clinical Trials? [Editorial]

Authors
L Minasian;J Unger
Journal / Conference
JCO Oncology Practice Mar;16(3):125-127
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
PMID32074016

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma (SWOG Intergroup S1826)

Authors
A Herrera;B Kahl
Journal / Conference
Hematologist [Clinical Trials Corner] Sept 1 Vol 17, Issue 5
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial

Authors
R Abrams;K Winter;H Safran;K Goodman;W Regine;A Berger;M Gilllin;PA Philip;A Lowy;A Wu;T DePetrillo;B Corn;S Seaward;M Haddock;S Song;Y Jiang;B Fisher;A Katz;S Mehta;C Willett;C Crane
Journal / Conference
American Journal of Clinical Oncology Mar;43(3):173-179
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID31985516
PMC
PMC7280743
Study Number(s)
CTSU/R0848

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)

Authors
D Kizub;J Miao;M Schubert;A Paterson;M Clemons;E Dees;J Ingle;C Falkson;W Barlow;G Hortobagyi;J Gralow
Journal / Conference
Supportive Care in Cancer Sep 15. doi: 10.1007/s00520-020-05748-8. Online ahead of print
Year
2020
Research Committee(s)
Breast
PMID
PMID32929540
Study Number(s)
S0307